English

Palomar Medical Technologies Inc.

EDGAR

Quarterly report (10-Q) · filed 2013-05-08

84 filing records in this dataset, filed from 1996-05-15 to 2013-05-08. Reported financial figures are available; chart coverage varies by period.

Inspect reported changes Compare with another company Historical disclosures Search filings Segments

Watchlist

Latest quarter

Revenue

23.2 million U001

2013 Q1 · U001

Exact inputs and evidence

Revenue: 23223059 U001 Source

Operating margin

-4.04%

2013 Q1 · %

Exact inputs and evidence

Operating Income: -938701 U001 Source
Revenue: 23223059 U001 Source

Operating cash flow

1.13 million U001

2013 Q1 · U001

Exact inputs and evidence

Operating Cash Flow: 1134170 U001 Source

Free cash flow

1.05 million U001

2013 Q1 · U001

Exact inputs and evidence

Operating Cash Flow: 1134170 U001 Source
Capital Expenditure: 80158 U001 Source

Cash and cash equivalents: 57.8 million U001 2013-03-31 Source
Exact value

57822604 U001
Long-term debt including current maturities: Not available
Shares outstanding: 20 million U002 2013-03-31 Source
Exact value

19974239 U002

Includes later revisions to earlier periods. Annual charts exclude incomplete years.

Latest filing recorded: 2013-05-08.

Financial data available through: 2012-12-31.

Coverage by financial measure

Revenue: 3 of 11 periods available· newest 2012-12-31
Operating income: 3 of 11 periods available· newest 2012-12-31
Net income: 3 of 11 periods available· newest 2012-12-31
Operating cash flow: 3 of 11 periods available· newest 2012-12-31
Capital expenditure: 3 of 11 periods available· newest 2012-12-31
Total assets: 2 of 11 periods available· newest 2012-12-31
Total liabilities: 2 of 11 periods available· newest 2012-12-31
Current assets: 2 of 11 periods available· newest 2012-12-31
Current liabilities: 2 of 11 periods available· newest 2012-12-31
Cash and cash equivalents: 4 of 11 periods available· newest 2012-12-31
long term debt: No compatible figures in this window
Shares outstanding: 2 of 11 periods available· newest 2012-12-31

Coverage describes values retained in this snapshot. Missing values are not zero; loading limits are reported separately.

What changed year over year

Latest complete year compared with the corresponding period one year earlier. These are measured changes; they do not establish their business causes.

Revenue
-22.1%

Prior period

U001 103.44 million

2011-01-01 – 2011-12-31
Current period

U001 80.57 million

2012-01-01 – 2012-12-31

Exact inputs and evidence

80573235 − 103436868 = -22863633 U001

103436868 U001 · 2011-01-01 – 2011-12-31
Inspect prior input Prior source
80573235 U001 · 2012-01-01 – 2012-12-31
Inspect current input Current source

Share or cite

Citation for Year-over-year change in Revenue · Palomar Medical Technologies Inc. · 2012-12-31 Palomar Medical Technologies Inc. (edgar:881695) Year-over-year change in Revenue: -22863633 U001 Concept: fundies:Revenue Period: 2012-01-01 to 2012-12-31 Values: Latest reported Published: 2026-11-02T13:38:09Z Snapshot: b8403f3577d1f20e481ab6f410379d013d5c21a271b041caea83fbcd8c57eb10 Dimensions: Consolidated View: https://fundies.io/companies/edgar/881695?view=overview&cadence=annual&surface=latest#period-changes-title Computed: Current period minus corresponding prior-year period Input fundies:Revenue: 80573235 U001 (2012-01-01 to 2012-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/881695/000088169513000006/pmti-20121231.xml#951136 Filing: 000088169513000006 Input fundies:Revenue: 103436868 U001 (2011-01-01 to 2011-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/881695/000088169513000006/pmti-20121231.xml#951263 Filing: 000088169513000006
The citation records this snapshot. The page link may show a newer release later.
Net income
-183.1%

Prior period

U001 7.43 million

2011-01-01 – 2011-12-31
Current period

−U001 6.17 million

2012-01-01 – 2012-12-31

Exact inputs and evidence

-6171159 − 7428429 = -13599588 U001

7428429 U001 · 2011-01-01 – 2011-12-31
Inspect prior input Prior source
-6171159 U001 · 2012-01-01 – 2012-12-31
Inspect current input Current source

Share or cite

Citation for Year-over-year change in Net income · Palomar Medical Technologies Inc. · 2012-12-31 Palomar Medical Technologies Inc. (edgar:881695) Year-over-year change in Net income: -13599588 U001 Concept: fundies:NetIncome Period: 2012-01-01 to 2012-12-31 Values: Latest reported Published: 2026-11-02T13:38:09Z Snapshot: b8403f3577d1f20e481ab6f410379d013d5c21a271b041caea83fbcd8c57eb10 Dimensions: Consolidated View: https://fundies.io/companies/edgar/881695?view=overview&cadence=annual&surface=latest#period-changes-title Computed: Current period minus corresponding prior-year period Input fundies:NetIncome: -6171159 U001 (2012-01-01 to 2012-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/881695/000088169513000006/pmti-20121231.xml#818014 Filing: 000088169513000006 Input fundies:NetIncome: 7428429 U001 (2011-01-01 to 2011-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/881695/000088169513000006/pmti-20121231.xml#818160 Filing: 000088169513000006
The citation records this snapshot. The page link may show a newer release later.
Operating cash flow
-266.2%

Prior period

U001 4.52 million

2011-01-01 – 2011-12-31
Current period

−U001 7.5 million

2012-01-01 – 2012-12-31

Exact inputs and evidence

-7502262 − 4515173 = -12017435 U001

4515173 U001 · 2011-01-01 – 2011-12-31
Inspect prior input Prior source
-7502262 U001 · 2012-01-01 – 2012-12-31
Inspect current input Current source

Share or cite

Citation for Year-over-year change in Operating cash flow · Palomar Medical Technologies Inc. · 2012-12-31 Palomar Medical Technologies Inc. (edgar:881695) Year-over-year change in Operating cash flow: -12017435 U001 Concept: fundies:OperatingCashFlow Period: 2012-01-01 to 2012-12-31 Values: Latest reported Published: 2026-11-02T13:38:09Z Snapshot: b8403f3577d1f20e481ab6f410379d013d5c21a271b041caea83fbcd8c57eb10 Dimensions: Consolidated View: https://fundies.io/companies/edgar/881695?view=overview&cadence=annual&surface=latest#period-changes-title Computed: Current period minus corresponding prior-year period Input fundies:OperatingCashFlow: -7502262 U001 (2012-01-01 to 2012-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/881695/000088169513000006/pmti-20121231.xml#823106 Filing: 000088169513000006 Input fundies:OperatingCashFlow: 4515173 U001 (2011-01-01 to 2011-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/881695/000088169513000006/pmti-20121231.xml#823344 Filing: 000088169513000006
The citation records this snapshot. The page link may show a newer release later.
Capital expenditure
-34.3%

Prior period

U001 979,495

2011-01-01 – 2011-12-31
Current period

U001 643,962

2012-01-01 – 2012-12-31

Exact inputs and evidence

643962 − 979495 = -335533 U001

979495 U001 · 2011-01-01 – 2011-12-31
Inspect prior input Prior source
643962 U001 · 2012-01-01 – 2012-12-31
Inspect current input Current source

Share or cite

Citation for Year-over-year change in Capital expenditure · Palomar Medical Technologies Inc. · 2012-12-31 Palomar Medical Technologies Inc. (edgar:881695) Year-over-year change in Capital expenditure: -335533 U001 Concept: fundies:CapitalExpenditure Period: 2012-01-01 to 2012-12-31 Values: Latest reported Published: 2026-11-02T13:38:09Z Snapshot: b8403f3577d1f20e481ab6f410379d013d5c21a271b041caea83fbcd8c57eb10 Dimensions: Consolidated View: https://fundies.io/companies/edgar/881695?view=overview&cadence=annual&surface=latest#period-changes-title Computed: Current period minus corresponding prior-year period Input fundies:CapitalExpenditure: 643962 U001 (2012-01-01 to 2012-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/881695/000088169513000006/pmti-20121231.xml#844256 Filing: 000088169513000006 Input fundies:CapitalExpenditure: 979495 U001 (2011-01-01 to 2011-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/881695/000088169513000006/pmti-20121231.xml#844491 Filing: 000088169513000006
The citation records this snapshot. The page link may show a newer release later.

Where revenue goes

How a period’s revenue divides into costs and what remains as profit. Items marked Derived are calculated by subtraction from reported figures.

2012 2012-01-01 – 2012-12-31

Revenue U001 80.57 million 100% of revenue
Cost of revenue U001 37.89 million 47% of revenue
Operating expenses U001 48.67 million 60% of revenue
Operating income −U001 5.99 million −7.4% of revenue
Tax, interest and other Derived U001 179,754 0.2% of revenue
Net income −U001 6.17 million −7.7% of revenue

Cash

Operating cash flow −U001 7.5 million −9.3% of revenue
Capital expenditure U001 643,962 0.8% of revenue
Free cash flow Derived −U001 8.15 million −10% of revenue

Share of revenue by period

Net income
Tax, interest and other
Operating costs

2010 Operating loss: operating costs were 114% of revenue.
2011 90%
2012 Operating loss: operating costs were 107% of revenue.

Values and sources

Revenue breakdown by annual reporting period
Period	Revenue	Operating costs	Operating income	Tax, interest and other	Net income	Free cash flow	Source
2010 2010-01-01 – 2010-12-31	63720885	72912470 Derived	-9191585	-416629 Derived	-8774956	-8044833 Derived	Source 2010-01-01 – 2010-12-31: 63720885 U001 Inspect Revenue Open source 2010-01-01 – 2010-12-31: -9191585 U001 Inspect Operating Income Open source 2010-01-01 – 2010-12-31: -8774956 U001 Inspect Net Income Open source 2010-01-01 – 2010-12-31: -4203987 U001 Inspect Operating Cash Flow Open source 2010-01-01 – 2010-12-31: 3840846 U001 Inspect Capital Expenditure Open source
2011 2011-01-01 – 2011-12-31	103436868	92699186 Derived	10737682	3309253 Derived	7428429	3535678 Derived	Source 2011-01-01 – 2011-12-31: 103436868 U001 Inspect Revenue Open source 2011-01-01 – 2011-12-31: 10737682 U001 Inspect Operating Income Open source 2011-01-01 – 2011-12-31: 7428429 U001 Inspect Net Income Open source 2011-01-01 – 2011-12-31: 4515173 U001 Inspect Operating Cash Flow Open source 2011-01-01 – 2011-12-31: 979495 U001 Inspect Capital Expenditure Open source
2012 2012-01-01 – 2012-12-31	80573235	86564640 Derived	-5991405	179754 Derived	-6171159	-8146224 Derived	Source 2012-01-01 – 2012-12-31: 80573235 U001 Inspect Revenue Open source 2012-01-01 – 2012-12-31: -5991405 U001 Inspect Operating Income Open source 2012-01-01 – 2012-12-31: -6171159 U001 Inspect Net Income Open source 2012-01-01 – 2012-12-31: -7502262 U001 Inspect Operating Cash Flow Open source 2012-01-01 – 2012-12-31: 643962 U001 Inspect Capital Expenditure Open source

Amounts are exact, in U001.

Growth

Sales over time and how quickly they are changing.

Revenue

Revenue reported for each complete financial period.

U001 80.6M 2012

Values and sources

Revenue values and source evidence
Period	Series	Value(U001)	Source evidence
20102010-12-31	Revenue	63720885	Revenue: 63720885 Open source
20112011-12-31	Revenue	103436868	Revenue: 103436868 Open source
20122012-12-31	Revenue	80573235	Revenue: 80573235 Open source

Revenue growth

Change in revenue from the same financial period one year earlier.

-22.1% 2012

Values and sources

Revenue growth values and source evidence
Period	Series	Value	Source evidence
20102010-12-31	Year over year	No prior comparable period	Revenue: 63720885 Open source
20112011-12-31	Year over year	62.3%	Revenue: 103436868 Open source Revenue: 63720885 Open source
20122012-12-31	Year over year	-22.1%	Revenue: 80573235 Open source Revenue: 103436868 Open source

Profit and cash

How much revenue becomes profit, and how much cash operations generate.

Profit margins

Operating income, net income and free cash flow as a share of revenue.

Operating margin -7.4% 2012

Net margin -7.7% 2012

Free cash flow margin -10.1% 2012

Operating margin
Net margin
Free cash flow margin

Values and sources

Profit margins values and source evidence
Period	Series	Value	Source evidence
20102010-12-31	Operating margin	-14.4%	Operating Income: -9191585 Open source Revenue: 63720885 Open source
20112011-12-31	Operating margin	10.4%	Operating Income: 10737682 Open source Revenue: 103436868 Open source
20122012-12-31	Operating margin	-7.4%	Operating Income: -5991405 Open source Revenue: 80573235 Open source
20102010-12-31	Net margin	-13.8%	Net Income: -8774956 Open source Revenue: 63720885 Open source
20112011-12-31	Net margin	7.2%	Net Income: 7428429 Open source Revenue: 103436868 Open source
20122012-12-31	Net margin	-7.7%	Net Income: -6171159 Open source Revenue: 80573235 Open source
20102010-12-31	Free cash flow margin	-12.6%	Revenue: 63720885 Open source Operating Cash Flow: -4203987 Open source Capital Expenditure: 3840846 Open source
20112011-12-31	Free cash flow margin	3.4%	Revenue: 103436868 Open source Operating Cash Flow: 4515173 Open source Capital Expenditure: 979495 Open source
20122012-12-31	Free cash flow margin	-10.1%	Revenue: 80573235 Open source Operating Cash Flow: -7502262 Open source Capital Expenditure: 643962 Open source

Operating cash flow

Cash generated by the company’s normal business operations.

U001 -7.5M 2012

Values and sources

Operating cash flow values and source evidence
Period	Series	Value(U001)	Source evidence
20102010-12-31	Operating cash flow	-4203987	Operating Cash Flow: -4203987 Open source
20112011-12-31	Operating cash flow	4515173	Operating Cash Flow: 4515173 Open source
20122012-12-31	Operating cash flow	-7502262	Operating Cash Flow: -7502262 Open source

Free cash flow

Operating cash flow minus capital expenditure for the same period and unit.

U001 -8.1M 2012

Values and sources

Free cash flow values and source evidence
Period	Series	Value(U001)	Source evidence
20102010-12-31	Free cash flow	-8044833	Operating Cash Flow: -4203987 Open source Capital Expenditure: 3840846 Open source
20112011-12-31	Free cash flow	3535678	Operating Cash Flow: 4515173 Open source Capital Expenditure: 979495 Open source
20122012-12-31	Free cash flow	-8146224	Operating Cash Flow: -7502262 Open source Capital Expenditure: 643962 Open source

Balance sheet

Liabilities and short-term ability to meet obligations at each period end.

Liabilities to assets

Total liabilities as a share of total assets.

10.8% 2012

Values and sources

Liabilities to assets values and source evidence
Period	Series	Value	Source evidence
2010-12-31	Liabilities / assets	Not reported	No source recorded
20112011-12-31	Liabilities / assets	13.2%	Total Liabilities: 23420287 Open source Total Assets: 178061480 Open source
20122012-12-31	Liabilities / assets	10.8%	Total Liabilities: 18263668 Open source Total Assets: 168828682 Open source

Current assets to current liabilities

Current assets divided by current liabilities.

8.62× 2012

Values and sources

Current assets to current liabilities values and source evidence
Period	Series	Value	Source evidence
2010-12-31	Current assets / current liabilities	Not reported	No source recorded
20112011-12-31	Current assets / current liabilities	6.1×	Current Assets: 119846531 Open source Current Liabilities: 19660091 Open source
20122012-12-31	Current assets / current liabilities	8.62×	Current Assets: 120985271 Open source Current Liabilities: 14034662 Open source

Cash generation

Compare reported profit with operating cash and capital spending. Free cash flow is calculated as operating cash flow minus capital expenditure when both exact, consolidated amounts match the same period and unit.

Cash generation by annual reporting period
Period	Net income	Operating cash flow	Capital expenditure	Free cash flow
2010 2010-01-01 – 2010-12-31	−U001 8.77 million Exact value Exact value: -8774956 U001 2010-01-01 – 2010-12-31: -8774956 U001 Inspect Net Income Open source Share or cite Citation for Net Income · Palomar Medical Technologies Inc. · 2010-12-31 Palomar Medical Technologies Inc. (edgar:881695) Net Income: -8774956 U001 Concept: fundies:NetIncome Period: 2010-01-01 to 2010-12-31 Values: Latest reported Published: 2026-11-02T13:38:09Z Snapshot: b8403f3577d1f20e481ab6f410379d013d5c21a271b041caea83fbcd8c57eb10 Dimensions: Consolidated View: https://fundies.io/companies/edgar/881695/explain?concept=fundies%3ANetIncome&period=2010-12-31&surface=latest&period_type=duration&start=2010-01-01&unit=U001&dimensions= Input fundies:NetIncome: -8774956 U001 (2010-01-01 to 2010-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/881695/000088169513000006/pmti-20121231.xml#818305 Filing: 000088169513000006 The citation records this snapshot. The page link may show a newer release later.	−U001 4.2 million Exact value Exact value: -4203987 U001 2010-01-01 – 2010-12-31: -4203987 U001 Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · Palomar Medical Technologies Inc. · 2010-12-31 Palomar Medical Technologies Inc. (edgar:881695) Operating Cash Flow: -4203987 U001 Concept: fundies:OperatingCashFlow Period: 2010-01-01 to 2010-12-31 Values: Latest reported Published: 2026-11-02T13:38:09Z Snapshot: b8403f3577d1f20e481ab6f410379d013d5c21a271b041caea83fbcd8c57eb10 Dimensions: Consolidated View: https://fundies.io/companies/edgar/881695/explain?concept=fundies%3AOperatingCashFlow&period=2010-12-31&surface=latest&period_type=duration&start=2010-01-01&unit=U001&dimensions= Input fundies:OperatingCashFlow: -4203987 U001 (2010-01-01 to 2010-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/881695/000088169513000006/pmti-20121231.xml#823581 Filing: 000088169513000006 The citation records this snapshot. The page link may show a newer release later.	U001 3.84 million Exact value Exact value: 3840846 U001 2010-01-01 – 2010-12-31: 3840846 U001 Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · Palomar Medical Technologies Inc. · 2010-12-31 Palomar Medical Technologies Inc. (edgar:881695) Capital Expenditure: 3840846 U001 Concept: fundies:CapitalExpenditure Period: 2010-01-01 to 2010-12-31 Values: Latest reported Published: 2026-11-02T13:38:09Z Snapshot: b8403f3577d1f20e481ab6f410379d013d5c21a271b041caea83fbcd8c57eb10 Dimensions: Consolidated View: https://fundies.io/companies/edgar/881695/explain?concept=fundies%3ACapitalExpenditure&period=2010-12-31&surface=latest&period_type=duration&start=2010-01-01&unit=U001&dimensions= Input fundies:CapitalExpenditure: 3840846 U001 (2010-01-01 to 2010-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/881695/000088169513000006/pmti-20121231.xml#844726 Filing: 000088169513000006 The citation records this snapshot. The page link may show a newer release later.	−U001 8.04 million Calculation and evidence -4203987 − 3840846 U001 Exact free cash flow: -8044833 U001 2010-01-01 – 2010-12-31: -4203987 U001 · Inspect Operating Cash Flow · Source 2010-01-01 – 2010-12-31: 3840846 U001 · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · Palomar Medical Technologies Inc. · 2010-12-31 Palomar Medical Technologies Inc. (edgar:881695) Free cash flow: -8044833 U001 Concept: free-cash-flow Period: 2010-01-01 to 2010-12-31 Values: Latest reported Published: 2026-11-02T13:38:09Z Snapshot: b8403f3577d1f20e481ab6f410379d013d5c21a271b041caea83fbcd8c57eb10 Dimensions: Consolidated View: https://fundies.io/companies/edgar/881695?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -4203987 U001 (2010-01-01 to 2010-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/881695/000088169513000006/pmti-20121231.xml#823581 Filing: 000088169513000006 Input fundies:CapitalExpenditure: 3840846 U001 (2010-01-01 to 2010-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/881695/000088169513000006/pmti-20121231.xml#844726 Filing: 000088169513000006 The citation records this snapshot. The page link may show a newer release later.
2011 2011-01-01 – 2011-12-31	U001 7.43 million Exact value Exact value: 7428429 U001 2011-01-01 – 2011-12-31: 7428429 U001 Inspect Net Income Open source Share or cite Citation for Net Income · Palomar Medical Technologies Inc. · 2011-12-31 Palomar Medical Technologies Inc. (edgar:881695) Net Income: 7428429 U001 Concept: fundies:NetIncome Period: 2011-01-01 to 2011-12-31 Values: Latest reported Published: 2026-11-02T13:38:09Z Snapshot: b8403f3577d1f20e481ab6f410379d013d5c21a271b041caea83fbcd8c57eb10 Dimensions: Consolidated View: https://fundies.io/companies/edgar/881695/explain?concept=fundies%3ANetIncome&period=2011-12-31&surface=latest&period_type=duration&start=2011-01-01&unit=U001&dimensions= Input fundies:NetIncome: 7428429 U001 (2011-01-01 to 2011-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/881695/000088169513000006/pmti-20121231.xml#818160 Filing: 000088169513000006 The citation records this snapshot. The page link may show a newer release later.	U001 4.52 million Exact value Exact value: 4515173 U001 2011-01-01 – 2011-12-31: 4515173 U001 Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · Palomar Medical Technologies Inc. · 2011-12-31 Palomar Medical Technologies Inc. (edgar:881695) Operating Cash Flow: 4515173 U001 Concept: fundies:OperatingCashFlow Period: 2011-01-01 to 2011-12-31 Values: Latest reported Published: 2026-11-02T13:38:09Z Snapshot: b8403f3577d1f20e481ab6f410379d013d5c21a271b041caea83fbcd8c57eb10 Dimensions: Consolidated View: https://fundies.io/companies/edgar/881695/explain?concept=fundies%3AOperatingCashFlow&period=2011-12-31&surface=latest&period_type=duration&start=2011-01-01&unit=U001&dimensions= Input fundies:OperatingCashFlow: 4515173 U001 (2011-01-01 to 2011-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/881695/000088169513000006/pmti-20121231.xml#823344 Filing: 000088169513000006 The citation records this snapshot. The page link may show a newer release later.	U001 979,495 Exact value Exact value: 979495 U001 2011-01-01 – 2011-12-31: 979495 U001 Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · Palomar Medical Technologies Inc. · 2011-12-31 Palomar Medical Technologies Inc. (edgar:881695) Capital Expenditure: 979495 U001 Concept: fundies:CapitalExpenditure Period: 2011-01-01 to 2011-12-31 Values: Latest reported Published: 2026-11-02T13:38:09Z Snapshot: b8403f3577d1f20e481ab6f410379d013d5c21a271b041caea83fbcd8c57eb10 Dimensions: Consolidated View: https://fundies.io/companies/edgar/881695/explain?concept=fundies%3ACapitalExpenditure&period=2011-12-31&surface=latest&period_type=duration&start=2011-01-01&unit=U001&dimensions= Input fundies:CapitalExpenditure: 979495 U001 (2011-01-01 to 2011-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/881695/000088169513000006/pmti-20121231.xml#844491 Filing: 000088169513000006 The citation records this snapshot. The page link may show a newer release later.	U001 3.54 million Calculation and evidence 4515173 − 979495 U001 Exact free cash flow: 3535678 U001 2011-01-01 – 2011-12-31: 4515173 U001 · Inspect Operating Cash Flow · Source 2011-01-01 – 2011-12-31: 979495 U001 · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · Palomar Medical Technologies Inc. · 2011-12-31 Palomar Medical Technologies Inc. (edgar:881695) Free cash flow: 3535678 U001 Concept: free-cash-flow Period: 2011-01-01 to 2011-12-31 Values: Latest reported Published: 2026-11-02T13:38:09Z Snapshot: b8403f3577d1f20e481ab6f410379d013d5c21a271b041caea83fbcd8c57eb10 Dimensions: Consolidated View: https://fundies.io/companies/edgar/881695?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: 4515173 U001 (2011-01-01 to 2011-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/881695/000088169513000006/pmti-20121231.xml#823344 Filing: 000088169513000006 Input fundies:CapitalExpenditure: 979495 U001 (2011-01-01 to 2011-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/881695/000088169513000006/pmti-20121231.xml#844491 Filing: 000088169513000006 The citation records this snapshot. The page link may show a newer release later.
2012 2012-01-01 – 2012-12-31	−U001 6.17 million Exact value Exact value: -6171159 U001 2012-01-01 – 2012-12-31: -6171159 U001 Inspect Net Income Open source Share or cite Citation for Net Income · Palomar Medical Technologies Inc. · 2012-12-31 Palomar Medical Technologies Inc. (edgar:881695) Net Income: -6171159 U001 Concept: fundies:NetIncome Period: 2012-01-01 to 2012-12-31 Values: Latest reported Published: 2026-11-02T13:38:09Z Snapshot: b8403f3577d1f20e481ab6f410379d013d5c21a271b041caea83fbcd8c57eb10 Dimensions: Consolidated View: https://fundies.io/companies/edgar/881695/explain?concept=fundies%3ANetIncome&period=2012-12-31&surface=latest&period_type=duration&start=2012-01-01&unit=U001&dimensions= Input fundies:NetIncome: -6171159 U001 (2012-01-01 to 2012-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/881695/000088169513000006/pmti-20121231.xml#818014 Filing: 000088169513000006 The citation records this snapshot. The page link may show a newer release later.	−U001 7.5 million Exact value Exact value: -7502262 U001 2012-01-01 – 2012-12-31: -7502262 U001 Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · Palomar Medical Technologies Inc. · 2012-12-31 Palomar Medical Technologies Inc. (edgar:881695) Operating Cash Flow: -7502262 U001 Concept: fundies:OperatingCashFlow Period: 2012-01-01 to 2012-12-31 Values: Latest reported Published: 2026-11-02T13:38:09Z Snapshot: b8403f3577d1f20e481ab6f410379d013d5c21a271b041caea83fbcd8c57eb10 Dimensions: Consolidated View: https://fundies.io/companies/edgar/881695/explain?concept=fundies%3AOperatingCashFlow&period=2012-12-31&surface=latest&period_type=duration&start=2012-01-01&unit=U001&dimensions= Input fundies:OperatingCashFlow: -7502262 U001 (2012-01-01 to 2012-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/881695/000088169513000006/pmti-20121231.xml#823106 Filing: 000088169513000006 The citation records this snapshot. The page link may show a newer release later.	U001 643,962 Exact value Exact value: 643962 U001 2012-01-01 – 2012-12-31: 643962 U001 Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · Palomar Medical Technologies Inc. · 2012-12-31 Palomar Medical Technologies Inc. (edgar:881695) Capital Expenditure: 643962 U001 Concept: fundies:CapitalExpenditure Period: 2012-01-01 to 2012-12-31 Values: Latest reported Published: 2026-11-02T13:38:09Z Snapshot: b8403f3577d1f20e481ab6f410379d013d5c21a271b041caea83fbcd8c57eb10 Dimensions: Consolidated View: https://fundies.io/companies/edgar/881695/explain?concept=fundies%3ACapitalExpenditure&period=2012-12-31&surface=latest&period_type=duration&start=2012-01-01&unit=U001&dimensions= Input fundies:CapitalExpenditure: 643962 U001 (2012-01-01 to 2012-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/881695/000088169513000006/pmti-20121231.xml#844256 Filing: 000088169513000006 The citation records this snapshot. The page link may show a newer release later.	−U001 8.15 million Calculation and evidence -7502262 − 643962 U001 Exact free cash flow: -8146224 U001 2012-01-01 – 2012-12-31: -7502262 U001 · Inspect Operating Cash Flow · Source 2012-01-01 – 2012-12-31: 643962 U001 · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · Palomar Medical Technologies Inc. · 2012-12-31 Palomar Medical Technologies Inc. (edgar:881695) Free cash flow: -8146224 U001 Concept: free-cash-flow Period: 2012-01-01 to 2012-12-31 Values: Latest reported Published: 2026-11-02T13:38:09Z Snapshot: b8403f3577d1f20e481ab6f410379d013d5c21a271b041caea83fbcd8c57eb10 Dimensions: Consolidated View: https://fundies.io/companies/edgar/881695?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -7502262 U001 (2012-01-01 to 2012-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/881695/000088169513000006/pmti-20121231.xml#823106 Filing: 000088169513000006 Input fundies:CapitalExpenditure: 643962 U001 (2012-01-01 to 2012-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/881695/000088169513000006/pmti-20121231.xml#844256 Filing: 000088169513000006 The citation records this snapshot. The page link may show a newer release later.

Capital expenditure uses the canonical mapped positive-spending convention. A missing, ambiguous, incompatible, or negative-sign input is left blank. Values use the latest reported version.

Dataset coverage and company identifiers

Coverage reflects filings processed into this Fundies dataset; it does not imply every source filing is loaded.

84 filings · 1,170 latest values · 1,170 originally reported values

Dataset published 2026-11-02. Source filing dates and reporting periods are shown separately.

Identifiers: 0000881695, 881695, edgar:881695

Also known as PALOMAR MEDICAL TECHNOLOGIES INC, PALOMAR MEDICAL TECHNOLOGIES INC , PALOMAR MEDICAL TECHNOLOGIES INC., PALOMAR MEDICAL TECHNOLOGIES LLC, Palomar Medical Technologies Inc.

Palomar Medical Technologies Inc.

Latest quarter

Revenue

Operating margin

Operating cash flow

Free cash flow

Company performance

What changed year over year

Revenue

Net income

Operating cash flow

Capital expenditure

Where revenue goes

2012 2012-01-01 – 2012-12-31

Cash

Share of revenue by period

Growth

Profit and cash

Balance sheet

Cash generation